0001595585-19-000250.txt : 20191107 0001595585-19-000250.hdr.sgml : 20191107 20191107192406 ACCESSION NUMBER: 0001595585-19-000250 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191105 FILED AS OF DATE: 20191107 DATE AS OF CHANGE: 20191107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alpern Robert J CENTRAL INDEX KEY: 0001448074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38558 FILM NUMBER: 191201771 MAIL ADDRESS: STREET 1: YALE SCHOOL OF MEDICINE STREET 2: 333 CEDAR STREET, C203 SHM CITY: NEW HAVEN STATE: CT ZIP: 06520 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tricida, Inc. CENTRAL INDEX KEY: 0001595585 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463372526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT, SUITE 201 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-429-7800 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT, SUITE 201 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 wf-form4_157317263109524.xml FORM 4 X0306 4 2019-11-05 0 0001595585 Tricida, Inc. TCDA 0001448074 Alpern Robert J 7000 SHORELINE COURT SUITE 201 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2019-11-05 4 S 0 1605 39.89 D 146168 D Common Stock 2019-11-06 4 S 0 227 39.75 D 145941 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.75 to $40.27, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. /s/ Edward J. Hejlek, attorney-in-fact 2019-11-07